Recent advancement of biologics in Asthma

Recent advancement of biologics in Asthma

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografiset tiedot
Päätekijä:	Evan, Al- Shahriar
Muut tekijät:	Sharmin, Sabrina
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	Brac University 2022
Aiheet:	Asthma Biologics Monoclonal-antibodies Lung capacity/function Interleukins Respiratory allergy Antiasthmatic agents
Linkit:	http://hdl.handle.net/10361/17590

Samankaltaisia teoksia

Biologics in the treatment of Severe Asthma
Tekijä: Hassan, Shah Musallin
Julkaistu: (2022)

Advancement of Antibody-Drug conjugates in cancer treatment: A review
Tekijä: Sagar, Baejid Hossain
Julkaistu: (2022)

Adult asthma /
Tekijä: Clark, T. J. H. (Timothy John Hayes)
Julkaistu: (1984)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
Tekijä: Tania, Umme
Julkaistu: (2021)

Osteoarthritis: a multi-disciplinary factual review
Tekijä: Subah, Nowshin
Julkaistu: (2021)

A review on targeted therapies for lung cancer
Tekijä: Ashraf, Anushey
Julkaistu: (2023)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
Tekijä: Fred, Namanda Rogers
Julkaistu: (2021)

In vivo propagation of monoclonal antibodies in ascites fluid produced in BALB/c mice: characterization and diagnostic application for the identification of Vibrio cholerae O1
Tekijä: Chowdhury, Mashiat Nawar
Julkaistu: (2018)

Dust mite allergy and the significance of different immunotherapies to treat It.
Tekijä: Ahasan, Faiyaz
Julkaistu: (2023)

Post Covid-19 health indications of Covid-19 patients
Tekijä: Khan, Tanzim
Julkaistu: (2022)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
Tekijä: Rithin, Rafia Islam
Julkaistu: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Tekijä: Islam, Nahidul
Julkaistu: (2023)

Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
Tekijä: Mehreen, Elnaj
Julkaistu: (2021)

Biomarkers in the diagnosis and treatment of Covid-19
Tekijä: Kabir, Syeda Shuvessa
Julkaistu: (2023)

Developing core economic parameter sets for asthma studies: A realist review and an analytical framework
Tekijä: Roukas, Chris, et al.
Julkaistu: (2022)

A review on recent advances in drugs for lung cancer treatment
Tekijä: Noor, Fouzia
Julkaistu: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
Tekijä: F. S. Amaral, André, et al.
Julkaistu: (2017)

PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
Tekijä: Lubaba, Anikah
Julkaistu: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
Tekijä: Choki, Kinley
Julkaistu: (2024)

Importance of biologics in rheumatoid arthritis management
Tekijä: Riyadh, S. M.
Julkaistu: (2022)

Comparative analysis of machine learning models for the prediction of asthma disease among the cardiovascular disease patients
Tekijä: Jahan, Asif
Julkaistu: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Tekijä: Tania, Umme
Julkaistu: (2023)

Molecules associated with the development of lung cancer
Tekijä: Rahman, Adree, et al.
Julkaistu: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Tekijä: Razna, Amrin Islam
Julkaistu: (2019)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Tekijä: Jeba, Joynob
Julkaistu: (2017)

In-silico approach of Fusion Glycoprotein (F) targeted multi-epitope vaccine against Human Respiratory Syncytial Virus (HRSV)
Tekijä: Sejan, Al Saba
Julkaistu: (2024)

A review on potential anticancer properties of antidiabetic drugs: metformin and sulfonylureas
Tekijä: Hossain, Tamara
Julkaistu: (2024)

Multi-hospital surveillance and antibiotic sensitivity among bacterial isolates of acute respiratory and enteric infection in underfive children in Dhaka, Bangladesh
Tekijä: Rahat, Asifuzzaman
Julkaistu: (2019)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Tekijä: Ratu, Tabassum
Julkaistu: (2024)

Potential of liposomes for the treatment of lung cancer- a review
Tekijä: Mim, Shanzida
Julkaistu: (2023)

Prevalence & antibiotic susceptibility patterns Of pathogens obtained from the lower respiratory tract Of patients from NIDCH Dhaka-Bangladesh
Tekijä: Gordon, Kisuule
Julkaistu: (2020)

Designing novel antibacterials: application of omics science
Tekijä: Zaman, Aubhishek M., et al.
Julkaistu: (2016)

Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers
Tekijä: Pranto, Hasan Al Reza
Julkaistu: (2022)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Tekijä: Rahman, Tasnim
Julkaistu: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Tekijä: Bristy, Israt Zerin
Julkaistu: (2021)

Availability of equipment and medications for non-communicable diseases and injuries at public first-referral level hospitals: A cross-sectional analysis of service provision assessments in eight low-income countries
Tekijä: Gupta, Neil, et al.
Julkaistu: (2022)

Advanced biology /
Tekijä: Simpkins, J. (John)
Julkaistu: (1989)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Tekijä: Hoque, Ismoth Ara
Julkaistu: (2024)

Deep neural network models for COVID-19 diagnosis from CT-Scan, explainability and analysis using trained models
Tekijä: Islam, Tahsin, et al.
Julkaistu: (2021)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Tekijä: Paul, Pulock
Julkaistu: (2024)